Neuromodulation has been investigated as a therapeutic modality for neuropsychiatric disorders, such as PTSD. Recent human clinical studies of transcranial magnetic stimulation (TMS) suggest some improvement in clinical symptomatology and EEG phenotype in PTSD patients with a short course of treatment. We hypothesize clinical improvement in patients with PTSD coinciding with changes in EEG measures.